Should Medicare add drugs to its list of benefits?

Greene, Jan
June 1999
H&HN: Hospitals & Health Networks;Jun99, Vol. 73 Issue 6, p24
Trade Publication
Comments on the addition of drugs to the list of benefits of Medicare. Importance of a system which lets private-sector plans offer seniors coverage that relies on choice and marketplace competition; Recommended sectors to receive Medicaid; Drug coverage for all beneficiaries in all plan options.


Related Articles

  • Medicare Card Launch Mediocre. J.W. // Pharmaceutical Executive;Jul2004, Vol. 24 Issue 7, p24 

    Focuses on issues and controversies surrounding the launch of the Medicare drug discount card on June 1, 2004. Claim of patient groups that the drug-company price increases are offsetting real savings from the card program; Counterclaim of the Pharmaceutical Research and Manufacturers of America...

  • D for Doomed? Huang, Wendy; Mozeson, Mark; Pesile, Jason // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p138 

    The article provides insights on problems associated with the implementation of the Medicare Modernization Act (MMA). According to the article, the U.S. government has underestimated the expenses involved in the implementation. Results from the Wall Street Journal/Harris Online survey showed...

  • Medicare coverage for patients with diabetes. A national plan with individual consequences. Ashkenazy, R.; Abrahamson, MJ.; Abrahamson, M J // JGIM: Journal of General Internal Medicine;Apr2006, Vol. 21 Issue 4, p386 

    The prevalence of diabetes in the U.S. Medicare population is growing at an alarming rate. From 1980 to 2004, the number of people aged 65 or older with diagnosed diabetes increased from 2.3 million to 5.8 million. According to the Centers for Medicare and Medicaid (CMS), 32% of Medicare...

  • Prescribing less expensive medicine. Barton, Joe // Fort Worth Business Press;4/24/2006, Vol. 19 Issue 17, Special section p3 

    Focuses on the enrollment of senior citizens in the Part D Medicare drug program under the Medicare Modernization Act in the U.S. Role of drugs in mitigating serious diseases; Number of Texans who are receiving prescription drug coverage under the program; Savings experienced by those who have...

  • Study of medicine prescribing for elderly patients. Freem, Charles B. // British Medical Journal (Clinical Research Edition);4/13/1985, Vol. 290 Issue 6475, p1113 

    Investigates medicine prescribing for elderly patients in Great Britain. Efficacy of the practice of prescribing for elderly patients; Common ailments in the elderly; List of drugs commonly included in the prescription.

  • Prescribing in old age. Swift, Cameron G. // British Medical Journal (Clinical Research Edition);3/26/1988, Vol. 296 Issue 6626, p913 

    Focuses on prescription practices for the aged. Requirements for health care among the elderly; Increase in the expenditure on drugs; Susceptibility of the aged to drug reactions.

  • CMS Eases Setup of Rehab Units At Critical Access Hospitals.  // PT: Magazine of Physical Therapy;Jul2004, Vol. 12 Issue 7, p69 

    Reports on the issuance of instructions that will make it easier for Medicare beneficiaries in rural areas to receive inpatient rehabilitation and psychiatric services in facilities near their homes in the U.S. Opportunity for critical access hospitals (CAH) to set aside beds; Payment of the...

  • Republicans are proposing changes in Medicare. Hanson, Cynthia; McLaughlin, Abraham // Christian Science Monitor;7/18/95, Vol. 87 Issue 162, p2 

    Reports on the changes proposed by the Republicans in Medicare that would impose spending limits and offer private health insurance to elderly beneficiaries.

  • Just Caring: In Defense of Limited Age-Based Healthcare Rationing. Fleck, Leonard M. // Cambridge Quarterly of Healthcare Ethics;Jan2010, Vol. 19 Issue 1, p27 

    An essay is presented on the need for surgically precise age-based healthcare rationing protocols in the U.S. It notes the need for more social resources to meet the health needs of the elderly and its limits. It emphasizes the adverse effects of purchasing expensive beneficial life-prolonging...

  • Medicare Drug Benefit Shapes Pharma R&D. Wechsler, Jill // Applied Clinical Trials;Oct2007, Vol. 16 Issue 10, p30 

    The author reflects on the impact of the Medicare prescription drug benefit program to the pharmaceutical industry in the U.S. She stresses that the success of the program has provided pharmaceutical coverage to millions of elderly patients. Moreover, she asserts that the program has also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics